Evidence map›Paper›PMID 31137660›Full record

ArticleInternational journal of molecular sciences2019

Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice.

Roberta Verta, Cristina Grange, Maura Gurrieri, Sara Borga, Patrizia Nardini, Monica Argenziano, Corrado Ghè, Roberta Cavalli, Elisa Benetti, Gianluca Miglio and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Histamine regulates the activity and the expression of the NaInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Roberta VertaDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. robertaverta94@gmail.com.
Cristina GrangeDepartment of Scienze Mediche, University of Turin, C.So Dogliotti 14, 10126 Turin, Italy. cristina.grange@unito.it.ORCID 0000-0002-6960-5476
Maura GurrieriDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. maura.gurrieri@live.it.
Sara BorgaDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. sara.borga@edu.unito.it.
Patrizia NardiniDepartment of Clinical and Experimental Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. patrizia.nardini@unifi.it.
Monica ArgenzianoDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. monica.argenziano@unito.it.
Corrado GhèDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. corrado.ghe@unito.it.
Roberta CavalliDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. roberta.cavalli@unito.it.
Elisa BenettiDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. elisa.benetti@unito.it.
Gianluca MiglioDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. gianluca.miglio@unito.it.
Benedetta BussolatiDepartment of Biotechnology and Health Sciences, Molecular Biotechnology Center University of Turin, Via Nizza 52, 10125 Turin, Italy. benedetta.bussolati@unito.it.ORCID 0000-0002-3663-5134
Alessandro PiniDepartment of Clinical and Experimental Medicine, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. alessandro.pini@unifi.it.
Arianna Carolina RosaDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy. ariannacarolina.rosa@unito.it.ORCID 0000-0002-6139-9241
University of Turin · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy is an unmet therapeutic need, and the search for new therapeutic strategies is warranted. Previous data point to histamine H

Indexed as

AnimalsBenzimidazolesDiabetic NephropathiesHistamine H1 AntagonistsKidneyMaleMiceMice, Inbred DBAPiperidinesBenzimidazolesbilastineHistamine H1 AntagonistsPiperidinesdiabeteshistaminehistamine H1 receptorkidneyslit diaphragm

Identifiers

PMID31137660
PMCPMC6566437
OpenAlexW2945246312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.